Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Species
- (2)
- (2)
- (6)
- (6)
- (6)
- (6)
- (2)
- (13)
- (1,863)
- (104)
- (1)
- (1)
- (4)
- (50)
- (5)
- (8)
- (2)
- (15)
- (1)
- (450)
- (8)
- (1)
- (28,374)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (13)
- (1)
- (7)
- (1)
- (3)
- (2)
- (3)
- (4)
- (3)
- (2)
- (4)
- (3)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (30,151)
- (196)
- (27)
- (19)
- (17)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (211)
- (2)
- (2)
- (1,043)
- (18)
- (2)
- (1)
- (2)
- (14)
- (1)
- (52)
- (2)
- (2)
- (2)
- (1)
- (42)
- (8)
- (44)
- (31)
- (2)
- (54)
- (4)
- (157)
- (172)
- (13)
- (12)
- (3)
- (6)
- (4)
- (120)
- (4)
- (3)
- (3)
- (2)
- (2)
- (2)
- (14)
- (30,025)
- (4)
- (4,513)
- (2)
- (4)
Regulatory Status
- (85)
- (93,816)
For Use With (Application)
- (3,448)
- (1)
- (28,534)
- (1)
- (65)
- (548)
- (9,418)
- (24)
- (1)
- (8)
- (2)
- (8)
- (2)
- (2)
- (1)
- (2)
- (53)
- (2)
- (2)
- (2)
- (1)
- (2)
- (2)
- (3)
- (1)
- (1)
- (5)
- (1)
- (1)
- (248)
- (27,118)
- (1)
- (1)
- (1)
- (28)
- (3)
- (49,021)
- (1,378)
- (2)
- (4)
- (32)
- (789)
- (4)
- (3)
- (2)
- (1)
- (118)
- (323)
- (1,551)
- (3)
- (62)
- (7)
- (3)
- (4)
- (19,645)
- (23)
- (32)
- (19)
- (180)
- (16)
- (3)
- (116)
- (151)
- (99)
- (1)
- (15)
- (3)
- (1)
- (1,605)
- (1)
- (4)
- (1)
- (35)
- (11)
- (2)
- (1)
- (2)
- (2)
- (9)
- (11)
- (2)
- (21,927)
- (4,209)
- (4)
- (5)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (47,864)
- (5)
- (2)
- (1)
- (62)
- (4)
- (5)
- (3)
- (6)
- (1)
- (1)
- (8,232)
- (4)
- (4)
- (1)
- (13)
- (2)
- (4)
- (11)
- (5)
- (5)
- (1)
- (49,059)
- (1,912)
Recombinant
- (12)
- (67,737)
- (19)
Form
- (3)
- (3)
- (49,857)
- (7,146)
- (3,526)
- (144)
- (16)
- (3,404)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
79,523
results
1
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco |
3
Promotions Available
Thermo Scientific™ Pierce™ Bovine Serum Albumin, Biotinylated
![]()
Thermo Scientific™ Pierce™ Bovine Serum Albumin, Biotinylated
Purified biotin and biotinylated BSA, HRP, AP or FITC for use as controls or to amplify signal in IHC via the avidin-biotin complex (ABC).
4
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | NTF3 |
| Molecular Weight (g/mol) | 27.2 kDa |
| Gene Symbol | Ntf3 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MYAEHKSHRG EYSVCDSESL WVTDKSSAID IRGHQVTVLG EIKTGNSPVK QYFYETRCKE ARPVKNGCRG IDDKHWNSQC KTSQTYVRAL TSENNKLVGW RWIRIDTSCV CALSRKIGRT |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Binding Assay,Bioactivity |
| Source | E. coli |
| Name | Human NT-3 |
| Accession Number | P20783 |
| Gene Alias | AI316846; AI835689; HDNF; Nerve growth factor 2; neurotrophic factor; neurotrophin 3; neurotrophin-3; neurotrophin-3 (HDNF/NT-3); NGF2; NGF-2; NT3; NT-3; NTF3; Ntf-3 |
| Biological Activity | Determined by its ability to bind recombinant human TrkB Fc Chimera in a functional ELISA. |
| Gene ID (Entrez) | 4908 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
5
Promotions Available
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
![]()
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | BDNF |
| Molecular Weight (g/mol) | 27 kDa |
| Gene Symbol | BDNF |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MHSDPARRGE LSVCDSISEW VTAADKKTAV DMSGGTVTVL EKVPVSKGQL KQYFYETKCN PMGYTKEGCR GIDKRHWNSQ CRTTQSYVRA LTMDSKKRIG WRFIRIDTSC VCTLTIKRGR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Binding Assay,Bioactivity |
| Source | E. coli |
| Name | Human/Mouse/Rat BDNF |
| Accession Number | P21237, P23363, P23560 |
| Gene Alias | abrineurin; ANON2; anorexia BDNF; Bdnf; BDNF precursor form; bdnf protein; brain derived neurothrophic factor; brain derived neurotrophic factor; brain-derived neurotrophic factor; BULN2; H-BDNF; neurotrophin; ProBDNF |
| Biological Activity | Determined by its ability to bind recombinant human TrkB Fc Chimera in a functional ELISA. |
| Gene ID (Entrez) | 12064, 24225, 627 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
6
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 38.2 kDa |
| Gene Symbol | Vegfa |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human VEGF-165 |
| Accession Number | P15692 |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Biological Activity | Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-10.0 ng/ml |
| Gene ID (Entrez) | 7422 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
7
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | NGF |
| Molecular Weight (g/mol) | 27 kDa |
| Gene Symbol | NGF |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | SSSHPIFHRG EFSVCDSVSV WVGDKTTATD IKGKEVMVLG EVNINNSVFK QYFFETKCRD PNPVDSGCRG IDSKHWNSYC TTTHTFVKAL TMDGKQAAWR FIRIDTACVC VLSRKAVRRA |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human beta-NGF |
| Accession Number | P01138 |
| Gene Alias | B nerve growth factor; beta ngf; beta-nerve growth factor; BetaNGF; beta-NGF; bNGF; b-NGF; HSAN5; MGC161426; MGC161428; Nerve growth factor; nerve growth factor (beta polypeptide); nerve growth factor, beta; nerve growth factor, beta polypeptide; nerve growth factor, beta subunit; NGF; NGF b; NGF β; Ngfb; NGFbeta; NGFβ; β nerve growth factor; β NGF; βNGF |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of human TF-1 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 4803 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
8
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-2 |
| Molecular Weight (g/mol) | 15.5 kDa |
| Gene Symbol | IL2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN RWITFAQSII STLT |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human IL-2 |
| Accession Number | P60568 |
| Gene Alias | aldesleukin; cytokine; H-IL-2; il 2; Il2; Il-2; ILN; Interleukin; interleukin 2; interleukin 2 precursor; interleukin 2 variant IL2delta2; Interleukin2; Interleukin-2; interleukin-2 precursor; interleukin-2 precursor protein; interleukin-2; interleukin 2; Involved in regulation of T cell clonal expansion; involved in regulation of T-cell clonal expansion; lymphokine; M-IL-2; patial sequence of Interleukin-2; POIL2; porcine Interleukin 2; T cell growth factor; T-cell growth factor; T-cell growth factor (TCGF); TCGF |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of murine CTLL-2 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 3558 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
10
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TGF beta-3 |
| Molecular Weight (g/mol) | 25 kDa |
| Gene Symbol | TGFB3 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | ALDTNYCFRN LEENCCVRPL YIDFRQDLGW KWVHEPKGYY ANFCSGPCPY LRSADTTHST VLGLYNTLNP EASASPCCVP QDLEPLTILY YVGRTPKVEQ LSNMVVKSCK CS |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human TGF-beta 3 |
| Accession Number | P10600 |
| Gene Alias | ARVD; ARVD1; FLJ16571; H-TGF-b-3; LAP; Latency-associated peptide; LDS5; prepro-transforming growth factor beta-3; RNHF; TGF beta 3; Tgfb3; TGF-B3; Tgfb-3; TGF-beta3; TGF-beta-3; Transforming growth factor; transforming growth factor beta 3; transforming growth factor beta precursor; transforming growth factor beta-3; Transforming growth factor beta-3 proprotein; transforming growth factor, beta 3; transforming growth factor-beta3 |
| Biological Activity | The ED50 was determined by TGF-beta3's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Gene ID (Entrez) | 7043 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
11
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-4 |
| Molecular Weight (g/mol) | 13.5 kDa |
| Gene Symbol | Il4 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MHIHGCDKNH LREIIGILNE VTGEGTPCTE MDVPNVLTAT KNTTESELVC RASKVLRIFY LKHGKTPCLK KNSSVLMELQ RLFRAFRCLD SSISCTMNES KSTSLKDFLE SLKSIMQMDY S |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Mouse IL-4 |
| Accession Number | P07750 |
| Gene Alias | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4delta2; interleukin 4 variant IL-4delta3; interleukin 4 variant IL-4int2A; interleukin 4 variant IL-4int3A; interleukin 4 variant IL-4int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
| Biological Activity | The ED50 was determined by the dose-dependent proliferation of murine HT-2 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Gene ID (Entrez) | 16189 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
13
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17.2 kDa |
| Gene Symbol | FGF2 |
| Endotoxin Concentration | <0.1 EU/μg |
| Sequence | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity |
| Source | E. coli |
| Name | Human FGF-basic (FGF-2/bFGF) (154 aa), Animal-Free |
| Accession Number | P09038 |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Biological Activity | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 2247 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
14
| Protein Family | Growth Factors & Receptors |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TGF beta-1 |
| Molecular Weight (g/mol) | 25 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Gene Symbol | Tgfb1 |
| Endotoxin Concentration | <0.1 ng/μg |
| For Use With (Application) | Bioactivity |
| Protein Subtype | TGFs (Transforming Growth Factors) |
| Name | Human TGF-beta 1 |
| Accession Number | P01137 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
| Protein Form | Recombinant, Ligand |
| Product Type | Protein |
| Gene ID (Entrez) | 7040 |
| Research Category | Immunology, Neurobiology, Oncology, Stem Cell Research, Cardiovascular Research, Differentiation, Bone Research |
| Species | Human |
| Product Line | Gibco |
| Recombinant | Recombinant |
15
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | HRG beta-1 |
| Molecular Weight (g/mol) | 7.5 kDa |
| Gene Symbol | Nrg1 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | SHLVKCAEKE KTFCVNGGEC FMVKDLSNPS RYLCKCPNEF TGDRCQNYVM ASFYKHLGIE FMEAE |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human Heregulin beta-1 |
| Accession Number | Q02297 |
| Gene Alias | 6030402G23Rik; acetylcholine receptor-inducing activity; ARIA; Breast cancer cell differentiation factor p45; D230005F13Rik; GGF; GGF2; GGFII; Glial growth factor; glial growth factor 2; heregulin; heregulin, alpha (45kD, ERBB2 p185-activator); Hgl; HRG; HRG1; HRGA; HRGalpha; MST131; MSTP131; NDF; Neu differentiation factor; neuregulin 1; neuregulin 1 type III beta 3; Neuregulin-1; Nrg1; NRG1-IT2; Pro-neuregulin-1, membrane-bound isoform; pro-NRG1; sensory and motor neuron derived factor; Sensory and motor neuron-derived factor; SMDF; type I neuregulin 1; type III neuregulin 1 |
| Biological Activity | The ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 10^6 units/mg |
| Gene ID (Entrez) | 3084 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |